[1] Wang, J.S. The second generation of proton pump inhibitor-Lansoprazole. Med.. Inf. J. 1995, 8, 42.
[2] Xu, H.; Yu, L.P.; Wen, J.; Zhao, W.; Huang, Y.D.; Li, X.K. The study of lansoprazole against experimental gastric ulcer effect. Chin. J. Pathol. 2002, 18, 698-700.
[3] Zhou, T.X. Clinical observation of lansoprazole in the treatment of reflux esophagitis. Chin. J. Clin. Rational. Drug Use. 2008, 1, 74-75.
[4] Wang, S.S. The effect of lansoprazole in the treatment of duodenal bleeding. China Med. Herald. 2011, 8, 66-67.
[5] Zhou, A.J.; Xu, F.Z.; Hu, Y. Clinical study of lansoprazole in the treatment of duodenal ulcer. J. Clin. Med. Pract. 2008, 12, 49-50.
[6] Xue, R.H. Observation of lansoprazole in the treatment of Helicobacter pylori positive duodenal ulcer. Chin. Med. J. Commun. 2005, 19, 454-455.
[7] Jian, W.J.; Li, G. Lansoprazole injection in the treatment of upper gastrointestinal hemorrhage curative effect observation. Northwest Pharm. J. 2008, 23, 320-321.
[8] Wei, X.L.; Dai, X.B.; Jiang, N.; Ma, L. Lansoprazole injection in the prevention and treatment of stress ulcer hemorrhage clinical observation. Hebei Med. J. 2011, 33, 2461-2462.
[9] Sun, S.Q.; Zhang, Z.Y.; Li, X.X.; Zhang, Y.S.; Tang, G.D.; Zhu, Xuan.; Zhu, R.M.; Wang, Q.; Zhang, F.X. Clinical experiment report of treating duodenal ulcer and hemorrhage with Lansoprazole for injection. Anhui Med. Pharm. J. 2008, 12, 955-957.
[10] Cao, Y.A.; Liu, L.C.; Ji, T.Q.; Liu, Y.L. The preparation, quality control and stability of lansoprazole injection were investigated. Chin. J. Pharm. Anal. 2009, 9, 1510-1513.
[11] He, X.J.; Chen, G.; Ding, X.F. Safety evaluation of lansoprazole for injection. Acad. J. Guangdong Coll. Pharm. 2005, 21, 163-166. The Japanese Takeda Lansoprazole for Injection listed instructions.
[12] Lansoprazole for Injection Japan Takeda dispensatory.
[13] Lansoprazole for Injection FDA dispensatory. |